Northern Trust
IRON icon

Northern Trust’s Disc Medicine IRON Stock Holding History

Northern Trust’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4M Buy
264,990
+17,795
+7% +$1.22M ﹤0.01% 1821
2026
Q1 		$15.8M Buy
247,195
+19,125
+8% +$1.33M ﹤0.01% 1818
2025
Q4 		$18.1M Buy
228,070
+8,581
+4% +$725K ﹤0.01% 1733
2025
Q3 		$14.5M Buy
219,489
+394
+0.2% +$23.4K ﹤0.01% 1896
2025
Q2 		$11.6M Buy
219,095
+10,282
+5% +$483K ﹤0.01% 1981
2025
Q1 		$10.4M Buy
208,813
+21,796
+12% +$1.21M ﹤0.01% 2019
2024
Q4 		$11.9M Buy
187,017
+16,299
+10% +$943K ﹤0.01% 2022
2024
Q3 		$8.39M Buy
170,718
+72,343
+74% +$3.4M ﹤0.01% 2166
2024
Q2 		$4.43M Buy
98,375
+987
+1% +$33.5K ﹤0.01% 2469
2024
Q1 		$6.06M Buy
97,388
+2,129
+2% +$138K ﹤0.01% 2348
2023
Q4 		$5.5M Buy
95,259
+6,221
+7% +$319K ﹤0.01% 2448
2023
Q3 		$4.18M Buy
89,038
+19,063
+27% +$954K ﹤0.01% 2544
2023
Q2 		$3.11M Buy
+69,975
New +$2.48M ﹤0.01% 2763
2022
Q4 		– Sell
-1,622
Closed -$80K – 4679
2022
Q3 		$80K Hold
1,622
– – ﹤0.01% 4188
2022
Q2 		$82K Sell
1,622
-4,889
-75% -$216K ﹤0.01% 4246
2022
Q1 		$272K Sell
6,511
-189
-3% -$9.91K ﹤0.01% 3998
2021
Q4 		$585K Sell
6,700
-152
-2% -$14.9K ﹤0.01% 3753
2021
Q3 		$830K Sell
6,852
-572
-8% -$78.2K ﹤0.01% 3608
2021
Q2 		$1.44M Buy
7,424
+5,517
+289% +$1.81M ﹤0.01% 3447
2021
Q1 		$775K Buy
+1,907
New +$851K ﹤0.01% 3681

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust's IRON Position: Q2 2026 in Review

Northern Trust increased its Disc Medicine (IRON) stake by 7.2% in Q2 2026, buying an estimated $1.22M and bringing the position to 264,990 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

Northern Trust first reported a position in IRON in Q1 2021 and has held it in 20 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Northern Trust held 264,990 shares of Disc Medicine worth $19.4M as of Q2 2026.
  • Northern Trust bought 17,795 Disc Medicine shares in Q2 2026, an estimated $1.22M.
  • Disc Medicine made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1821 holding.
  • Northern Trust first reported a position in Disc Medicine in Q1 2021 and has held it in 20 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.